These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 1641486
1. [Positron emission tomography of the thorax. The current clinical status]. Knopp MV, Bischoff H, Oberdorfer F, van Kaick G. Radiologe; 1992 Jun; 32(6):290-5. PubMed ID: 1641486 [Abstract] [Full Text] [Related]
2. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Rege SD, Hoh CK, Glaspy JA, Aberle DR, Dahlbom M, Razavi MK, Phelps ME, Hawkins RA. Cancer; 1993 Jul 01; 72(1):82-90. PubMed ID: 8389668 [Abstract] [Full Text] [Related]
3. Positron emission tomography, bronchogenic carcinoma, and the adrenals. Lamki LM. AJR Am J Roentgenol; 1997 May 01; 168(5):1361-2. PubMed ID: 9129445 [No Abstract] [Full Text] [Related]
4. Introduction to clinical positron emission tomography. Agress H. N J Med; 2000 Oct 01; 97(10):25-30. PubMed ID: 11064564 [Abstract] [Full Text] [Related]
9. [Value of positron emission tomography in treatment of lymphoma patients]. Kuwert T. Strahlenther Onkol; 2001 Mar 01; 177(3):160-1. PubMed ID: 11285774 [No Abstract] [Full Text] [Related]
10. The status of SPECT in tumor diagnosis. DeLand FH, Shih WJ. J Nucl Med; 1984 Dec 01; 25(12):1375-9. PubMed ID: 6389792 [No Abstract] [Full Text] [Related]
11. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, Jingu K, Masuda K. J Nucl Med; 1991 Sep 01; 32(9):1655-60. PubMed ID: 1880564 [Abstract] [Full Text] [Related]
12. Similar pelvic abnormalities on FDG positron emission tomography of different origins. Zhuang H, Yamamoto AJ, Sinha P, Pourdehnad M, Liu Y, Alavi A. Clin Nucl Med; 2001 Jun 01; 26(6):515-7. PubMed ID: 11353298 [Abstract] [Full Text] [Related]
13. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. Hoekstra OS, Ossenkoppele GJ, Golding R, van Lingen A, Visser GW, Teule GJ, Huijgens PC. J Nucl Med; 1993 Oct 01; 34(10):1706-10. PubMed ID: 8410287 [Abstract] [Full Text] [Related]
14. [Fluorodeoxyglucose and bronchopulmonary cancer. Initial French results with positron emission tomography]. Vaylet F, Foehrenbach H, De Dreuille O, Maszelin P, Merlet P, Bendriem B, L'Her P, Syrota A, Gaillard JF. Rev Pneumol Clin; 1998 Sep 01; 54(4):187-95. PubMed ID: 9805748 [Abstract] [Full Text] [Related]
15. [18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas. Kostakoglu L. Clin Lymphoma Myeloma; 2008 Oct 01; 8(5):273-6. PubMed ID: 18854280 [No Abstract] [Full Text] [Related]
16. [Diagnostic techniques for bronchial cancer. New scintigraphic techniques (immunoscintigraphy and positron-emission tomography)]. Vaylet F, Vuillez JP. Rev Mal Respir; 1999 Jan 01; 16 Suppl 3():S78-82. PubMed ID: 10088259 [No Abstract] [Full Text] [Related]
18. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. Okada J, Yoshikawa K, Imazeki K, Minoshima S, Uno K, Itami J, Kuyama J, Maruno H, Arimizu N. J Nucl Med; 1991 Apr 01; 32(4):686-91. PubMed ID: 2013808 [Abstract] [Full Text] [Related]
19. Positron emission tomography in the management of lymphomas: a summary. O'Doherty MJ, Hoskin PJ. Eur J Nucl Med Mol Imaging; 2003 Jun 01; 30 Suppl 1():S128-30. PubMed ID: 12692689 [No Abstract] [Full Text] [Related]
20. [Evaluation of pulmonary lesions with positron emission tomography]. Knopp MV, Bischoff HG. Radiologe; 1994 Oct 01; 34(10):588-91. PubMed ID: 7816916 [Abstract] [Full Text] [Related] Page: [Next] [New Search]